KSL · 4h
Sen. Sanders says middlemen won't punish Novo if it cuts weight-loss drug prices
Sen. Bernie Sanders said on Tuesday he had commitments from the nation's top pharmacy benefit managers that they would expand coverage of Novo Nordisk's popular diabetes and weight-loss medicines if the company lowered the list prices.
CNN · 7h
‘Greed, greed, greed’: Sanders demands Ozempic maker lower prices
While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, on Tuesday, Sen. Bernie Sanders alleged that 40,000 people a year in the US could die if the company doesn’t make the medicines more affordable.
Yahoo · 11h
Ozempic producer CEO in hot seat in Senate hearing over cost of weight loss drug
Senators grilled Novo Nordisk CEO Lars Jorgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight loss drugs. The drugs have risen in popularity for diabetic patients and others looking to combat obesity since they were approved,
Some results have been hidden because they may be inaccessible to you
Show inaccessible results